eFFECTOR Therapeutics (EFTR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Jul6

eFFECTOR Therapeutics ceases operations and seeks strategic options

18:06

Jun26

EFFECTOR Therapeutics received a default notice from Oxford Finance

10:18

May20

eFFECTOR Therapeutics collaborates with Dana-Farber Cancer Institute for clinical trial

13:25

Schedules & Filings

Schedules

Filings

May9

Earning Release(EST)

FY2024 Q1 Earning Release (USD) Net Income -8.834 M, EPS -2.1643

Mar25

Earning Release(EST)

FY2023 Q4 Earning Release (USD) Net Income -9.13 M, EPS -3.4195

Jan12

Reverse Stock Split(EST)

1-for-25 Reverse Stock Split

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change